Stay updated on Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and displays recruitment status as 'No longer looking for participants'. The Intervention/Treatment heading is updated and the revision footer shows Revision: v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:28:36.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page displays an updated revision label: Revision: v3.5.5, replacing the previous Revision: v3.5.4.
    Difference
    0.1%
    Check dated 2026-06-05T13:26:51.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision metadata on the page was updated to v3.5.4, indicating a newer document version and replacing the prior v3.5.3 tag.
    Difference
    0.1%
    Check dated 2026-05-15T05:57:40.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page’s software/display footer revision was updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T06:02:13.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:36:45.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T06:07:16.000Z thumbnail image

Stay in the know with updates to Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.